
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Research and Evaluation Department, Kaiser Permanente Medical Care Program, Southern California, Pasadena, California 91188 [S. M. E.], and Department of Preventive Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California 90033 [S. M. E., R. K. R., A. P-H., C. L. C., L. B.]
We evaluated whether our previous reports of increased
postmenopausal breast cancer risk with higher body mass index (BMI) or
of reduced premenopausal and postmenopausal breast cancer risk with
higher physical activity levels varied according to the tumors
estrogen receptor (ER) and progesterone receptor (PR) status.
Participants enrolled in either of two population-based case-control
studies in Los Angeles County, California: one of premenopausal women
(ages
40 years), and one of postmenopausal women (ages 5564 years).
Case participants were diagnosed for the first time with in
situ or invasive breast cancer from 7/1/83 through 12/31/88
(premenopausal women) or from 3/1/87 through 12/31/89
(postmenopausal women). Joint ER/PR status was collected for 424
premenopausal and 760 postmenopausal case participants. The analysis
included 714 premenopausal and 1091 postmenopausal age-matched,
race-matched (white or Hispanic), parity-matched (premenopausal women
only), and residential neighborhood-matched control participants.
Among the postmenopausal women, obesity was associated with an
increased odds of ER+/PR+ breast cancer (odds ratio, 2.45 for women in
the highest versus the lowest body mass index quartile;
95% confidence interval, 1.733.47). Body mass index was associated
with neither ER-/PR- tumors among the postmenopausal women nor with
any ER/PR subgroup among the premenopausal women. For both
premenopausal and postmenopausal women, higher recreational physical
activity levels (
17.6 MET-hours/week versus no
activity) were associated with a 3060% reduction in risk of nearly
all ER/PR subtypes, although the associations were generally of
borderline statistical significance. Examining these potentially
modifiable breast cancer risk factors by tumor ER and PR status may
provide us with greater insight into breast cancer etiology and the
mechanisms underlying the risk factor associations.
This article has been cited by other articles:
![]() |
J. Ahn, A. Schatzkin, J. V. Lacey Jr, D. Albanes, R. Ballard-Barbash, K. F. Adams, V. Kipnis, T. Mouw, A. R. Hollenbeck, and M. F. Leitzmann Adiposity, Adult Weight Change, and Postmenopausal Breast Cancer Risk Arch Intern Med, October 22, 2007; 167(19): 2091 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Dallal, J. Sullivan-Halley, R. K. Ross, Y. Wang, D. Deapen, P. L. Horn-Ross, P. Reynolds, D. O. Stram, C. A. Clarke, H. Anton-Culver, et al. Long-term Recreational Physical Activity and Risk of Invasive and In Situ Breast Cancer: The California Teachers Study Arch Intern Med, February 26, 2007; 167(4): 408 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Lahmann, C. Friedenreich, A. J. Schuit, S. Salvini, N. E. Allen, T. J. Key, K.-T. Khaw, S. Bingham, P. H.M. Peeters, E. Monninkhof, et al. Physical Activity and Breast Cancer Risk: The European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 36 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bardia, L. C. Hartmann, C. M. Vachon, R. A. Vierkant, A. H. Wang, J. E. Olson, T. A. Sellers, and J. R. Cerhan Recreational Physical Activity and Risk of Postmenopausal Breast Cancer Based on Hormone Receptor Status Arch Intern Med, December 11, 2006; 166(22): 2478 - 2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. U. Rosenberg, K. Einarsdottir, E. I. Friman, S. Wedren, P. W. Dickman, P. Hall, and C. Magnusson Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2482 - 2488. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Michels, K. L. Terry, and W. C. Willett Longitudinal Study on the Role of Body Size in Premenopausal Breast Cancer Arch Intern Med, November 27, 2006; 166(21): 2395 - 2402. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cho, W. Y. Chen, D. J. Hunter, M. J. Stampfer, G. A. Colditz, S. E. Hankinson, and W. C. Willett Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med, November 13, 2006; 166(20): 2253 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Adams, C. E. Matthews, J. R. Hebert, C. G. Moore, J. E. Cunningham, X.-O. Shu, J. Fulton, Y. Gao, and W. Zheng Association of physical activity with hormone receptor status: the shanghai breast cancer study. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1170 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tehard, C. M. Friedenreich, J.-M. Oppert, and F. Clavel-Chapelon Effect of Physical Activity on Women at Increased Risk of Breast Cancer: Results from the E3N Cohort Study Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Yumuk and P. F. Yumuk What Links Obesity to Cancer? Indoor and Built Environment, December 1, 2005; 14(6): 527 - 532. [Abstract] [PDF] |
||||
![]() |
L. Bernstein, A. V. Patel, G. Ursin, J. Sullivan-Halley, M. F. Press, D. Deapen, J. A. Berlin, J. R. Daling, J. A. McDonald, S. A. Norman, et al. Lifetime Recreational Exercise Activity and Breast Cancer Risk Among Black Women and White Women J Natl Cancer Inst, November 16, 2005; 97(22): 1671 - 1679. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Eng, M. D. Gammon, M. B. Terry, L. H. Kushi, S. L. Teitelbaum, J. A. Britton, and A. I. Neugut Body Size Changes in Relation to Postmenopausal Breast Cancer among Women on Long Island, New York Am. J. Epidemiol., August 1, 2005; 162(3): 229 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Loi, R. L. Milne, M. L. Friedlander, M. R.E. McCredie, G. G. Giles, J. L. Hopper, and K.-A. Phillips Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1686 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Lee, J.-Y. Choi, C. Kang, C. P. Kang, S. K. Park, H. Cho, D.-Y. Cho, K.-Y. Yoo, D.-Y. Noh, S.-H. Ahn, et al. Genetic Polymorphisms of Selected DNA Repair Genes, Estrogen and Progesterone Receptor Status, and Breast Cancer Risk Clin. Cancer Res., June 15, 2005; 11(12): 4620 - 4626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Cummings, J. S. Lee, L.-Y. Lui, K. Stone, B. M. Ljung, J. A. Cauleys, and for the Study of Osteoporotic Fractures Research G Sex Hormones, Risk Factors, and Risk of Estrogen Receptor-Positive Breast Cancer in Older Women: A Long-term Prospective Study Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1047 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Nichols, A. Trentham-Dietz, R. R. Love, J. M. Hampton, P. T. Hoang Anh, D. C. Allred, S. K. Mohsin, and P. A. Newcomb Differences in Breast Cancer Risk Factors by Tumor Marker Subtypes among Premenopausal Vietnamese and Chinese Women Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 41 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Gorla, N. Hou, S. Acharya, A. Rademaker, S. Khan, V. Staradub, and M. Morrow A Predictive Model for the Development of Hormone-Responsive Breast Cancer Ann. Surg. Oncol., January 1, 2005; 12(1): 48 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rundle Molecular Epidemiology of Physical Activity and Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. MacInnis, D. R. English, D. M. Gertig, J. L. Hopper, and G. G. Giles Body Size and Composition and Risk of Postmenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2117 - 2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Althuis, J. H. Fergenbaum, M. Garcia-Closas, L. A. Brinton, M. P. Madigan, and M. E. Sherman Etiology of Hormone Receptor-Defined Breast Cancer: A Systematic Review of the Literature Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1558 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cotterchio, N. Kreiger, B. Theis, M. Sloan, and S. Bahl Hormonal Factors and the Risk of Breast Cancer According to Estrogen- and Progesterone-Receptor Subgroup Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1053 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Dignam, K. Wieand, K. A. Johnson, B. Fisher, L. Xu, and E. P. Mamounas Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer J Natl Cancer Inst, October 1, 2003; 95(19): 1467 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. McTiernan, C. Kooperberg, E. White, S. Wilcox, R. Coates, L. L. Adams-Campbell, N. Woods, and J. Ockene Recreational Physical Activity and the Risk of Breast Cancer in Postmenopausal Women: The Women's Health Initiative Cohort Study JAMA, September 10, 2003; 290(10): 1331 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, S. C. Juneja, N. J. Maihle, and M. P. Cleary RESPONSE: Re: Leptin--A Growth Factor in Normal and Malignant Breast Cells and for Normal Mammary Gland Development J Natl Cancer Inst, August 6, 2003; 95(15): 1173 - 1174. [Full Text] [PDF] |
||||
![]() |
A. McTiernan Behavioral Risk Factors in Breast Cancer: Can Risk Be Modified? Oncologist, August 1, 2003; 8(4): 326 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cho, D. Spiegelman, D. J. Hunter, W. Y. Chen, M. J. Stampfer, G. A. Colditz, and W. C. Willett Premenopausal Fat Intake and Risk of Breast Cancer J Natl Cancer Inst, July 16, 2003; 95(14): 1079 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Li, J. R. Daling, and K. E. Malone Incidence of Invasive Breast Cancer by Hormone Receptor Status From 1992 to 1998 J. Clin. Oncol., January 1, 2003; 21(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Britton, M. D. Gammon, J. B. Schoenberg, J. L. Stanford, R. J. Coates, C. A. Swanson, N. Potischman, K. E. Malone, D. J. Brogan, J. R. Daling, et al. Risk of Breast Cancer Classified by Joint Estrogen Receptor and Progesterone Receptor Status among Women 20-44 Years of Age Am. J. Epidemiol., September 15, 2002; 156(6): 507 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Li, K. E. Malone, and J. R. Daling Differences in Breast Cancer Hormone Receptor Status and Histology by Race and Ethnicity among Women 50 Years of Age and Older Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 601 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Stoll Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications Ann. Onc., February 20, 2002; 13(2): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ursin, C.-C. Tseng, A. Paganini-Hill, S. Enger, P. C. Wan, S. Formenti, M. C. Pike, and R. K. Ross Does Menopausal Hormone Replacement Therapy Interact With Known Factors to Increase Risk of Breast Cancer? J. Clin. Oncol., February 1, 2002; 20(3): 699 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Sellers, J. Davis, J. R. Cerhan, R. A. Vierkant, J. E. Olson, V. S. Pankratz, J. D. Potter, and A. R. Folsom Interaction of Waist/Hip Ratio and Family History on the Risk of Hormone Receptor-defined Breast Cancer in a Prospective Study of Postmenopausal Women Am. J. Epidemiol., February 1, 2002; 155(3): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |